effect overlay
activetrials
Brain Tumour/Neurosurgery

Quality of life outcomes in low-grade glioma and benign brain tumour

HREC: 2013.246
Principal Investigator: Prof Kate Drummond
Coordinator contact: Dr Sarah Cain
Funding: Non-Commercial
Brain Tumour/Neurosurgery

The effects of Cerebrospinal fluid (CSF) diversion on post-operative CSF leak following extended endoscopic anterior skull base surgery

HREC: 2016.234
Principal Investigator: Prof Kate Drummond
Coordinator contact:
Funding: Non-Commercial
Brain Tumour/Neurosurgery

Fatigue, Anxiety and Cognition survey (FACs) following Neurosurgical procedures

HREC: 2018.127
Principal Investigator: Prof Kate Drummond
Coordinator contact:
Funding: Non-Commercial
Dementia

A Phase IIa Study of ANAVEX2-73 Adaptive Trial Design with repeated doses, Maximum Tolerated Dose Finding, Pharmacodynamic Investigation and Bioavailability Evaluation in Patients with Mild to Moderate Alzheimer’s Disease With a 52 week Open Label Follow-Up period 
 

HREC: 2016.097
Principal Investigator: Dr Christopher Kyndt
Coordinator contact: Lauren Martell
Funding: Commercial
Dementia

Deferiprone to Delay Dementia (The 3D Study): a clinical proof of cencept study
 

HREC: 2017.172
Principal Investigator: Dr Christopher Kyndt
Coordinator contact: Lauren Martell
Funding: Commercial